RRP7A Activators encompass a diverse array of chemical compounds that interface with intracellular signaling pathways in order to enhance the functional activity of RRP7A. Compounds such as Forskolin and Dibutyryl-cAMP function by increasing intracellular cAMP levels, thereby activating PKA, which can phosphorylate a variety of proteins. This can result in either direct phosphorylation of RRP7A or phosphorylation of proteins that associate with RRP7A, leading to its activation. Similarly, PMA and Anisomycin act via the activation of PKC and SAPKs, respectively, which can also modulate phosphorylation states within the cell andaffect RRP7A activity. Ionomycin, through its role as a calcium ionophore, increases intracellular calcium concentrations and activates calcium-dependent kinases, which could influence RRP7A activity through downstream phosphorylation events.
Compounds such as Okadaic Acid play a role in modulating the phosphorylation status within the cell by inhibiting phosphatases, which could lead to an increase in the phosphorylated state of proteins that interact with RRP7A, potentially enhancing its function. Insulin and Isoproterenol influence the PI3K/Akt and beta-adrenergic signaling pathways, respectively, leading to downstream effects that may include the phosphorylation of proteins that modulate RRP7A activity. The modulation of gene expression by Retinoic Acid can lead to changes in the cellular milieu, potentially increasing the expression of proteins that interact with and enhance the functional activity of RRP7A.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, resulting in increased levels of cAMP, a secondary messenger that can enhance protein kinase A (PKA) activity. PKA can phosphorylate various proteins, potentially including RRP7A, or proteins that associate with RRP7A, leading to its functional enhancement. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in various signal transduction pathways. Activation of PKC could lead to phosphorylation events that enhance the activity or interactions of RRP7A with other cellular proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent kinases such as calmodulin-dependent kinase (CaMK), potentially modulating RRP7A activity through phosphorylation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation leads to the PI3K/Akt signaling pathway's stimulation. Akt can phosphorylate a wide array of substrates that may include proteins that modulate the function of RRP7A, resulting in its enhanced activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. This activation can lead to phosphorylation of proteins that either physically interact with RRP7A, enhancing its functional activity, or modulate its activity indirectly. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, resulting in increased phosphorylation levels of cellular proteins. This could maintain RRP7A in a hyperphosphorylated state, potentially enhancing its activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), like JNK. This action can lead to phosphorylation of proteins that interact with RRP7A, thereby enhancing its functional activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can lead to increased cAMP levels and PKA activation. This can theoretically result in phosphorylation of proteins that enhance the functional activity of RRP7A. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences gene expression by activating nuclear receptors. It can modulate the expression of genes encoding proteins that interact with or modulate RRP7A, potentially enhancing its functional activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can affect multiple signaling pathways, including the inhibition of NF-kB activation. This could lead to altered expression of proteins that interact with RRP7A, resulting in its functional activation. | ||||||